Capital Advisors, Ltd. LLC Abb Vie Inc. Transaction History

Capital Advisors, Ltd. LLC

$806 Million
Q3 2024

A detailed history of Capital Advisors, Ltd. LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 3,919 shares of ABBV stock, worth $705,420. This represents 0.1% of its overall portfolio holdings.

Number of Shares

3,919

Previous 4,453 11.99%

Holding current value

$705,420

Previous $764,000 1.31%

% of portfolio

0.1%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$163.84 - $199.33 $87,490 - $106,442	-534 Reduced 11.99%	3,919 $774,000
Q2 2024 Jul 25, 2024	BUY	$154.79 - $180.76 $8,513 - $9,941	55 Added 1.25%	4,453 $764,000
Q1 2024 Apr 18, 2024	BUY	$159.82 - $182.1 $20,456 - $23,308	128 Added 3.0%	4,398 $801,000
Q4 2023 Feb 02, 2024	SELL	$137.6 - $154.97 $10,870 - $12,242	-79 Reduced 1.82%	4,270 $662,000
Q3 2023 Oct 27, 2023	SELL	$133.59 - $154.65 $17,633 - $20,413	-132 Reduced 2.95%	4,349 $648,000
Q2 2023 Jul 26, 2023	BUY	$132.51 - $164.9 $13,648 - $16,984	103 Added 2.35%	4,481 $604,000
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $91,104 - $104,920	-630 Reduced 12.58%	4,378 $698,000
Q4 2022 Feb 07, 2023	BUY	$138.31 - $165.87 $115,073 - $138,003	832 Added 19.92%	5,008 $701,000
Q3 2022 Nov 09, 2022	BUY	$134.21 - $153.93 $17,715 - $20,318	132 Added 3.26%	4,176 $560,000
Q2 2022 Aug 05, 2022	BUY	$137.62 - $174.96 $137 - $174	1 Added 0.02%	4,044 $619,000
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $69,289 - $85,968	525 Added 14.92%	4,043 $655,000
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $70,903 - $89,713	660 Added 23.09%	3,518 $476,000
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $137,043 - $155,564	1,288 Added 82.04%	2,858 $308,000
Q2 2021 Aug 10, 2021	BUY	$105.21 - $117.21 $210 - $234	2 Added 0.13%	1,570 $177,000
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $102 - $112	1 Added 0.06%	1,568 $170,000
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $80 - $108	1 Added 0.06%	1,567 $168,000
Q3 2020 Nov 03, 2020	BUY	$85.91 - $100.83 $171 - $201	2 Added 0.13%	1,566 $137,000
Q2 2020 Aug 06, 2020	BUY	$73.37 - $98.18 $73 - $98	1 Added 0.06%	1,564 $154,000
Q1 2020 May 08, 2020	BUY	$64.5 - $97.79 $6,256 - $9,485	97 Added 6.62%	1,563 $119,000
Q4 2019 Feb 03, 2020	BUY	$72.13 - $90.25 $72 - $90	1 Added 0.07%	1,466 $130,000
Q3 2019 Oct 23, 2019	BUY	$62.98 - $75.72 $125 - $151	2 Added 0.14%	1,465 $111,000
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $26,345 - $33,675	401 Added 37.76%	1,463 $106,000
Q1 2019 May 01, 2019	BUY	$77.14 - $90.79 $154 - $181	2 Added 0.19%	1,062 $86,000
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $77 - $96	1 Added 0.09%	1,060 $98,000
Q3 2018 Oct 24, 2018	BUY	$88.91 - $98.84 $88 - $98	1 Added 0.09%	1,059 $100,000
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $89 - $106	1 Added 0.09%	1,058 $98,000
Q4 2017 Jan 16, 2018	BUY	$89.56 - $98.21 $89 - $98	1 Added 0.09%	1,057 $102,000
Q3 2017 Oct 25, 2017	BUY	$69.85 - $89.22 $73,761 - $94,216	1,056	1,056 $94,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.

Account

Capital Advisors, Ltd. LLC Abb Vie Inc. Transaction History